Richard Kronmal, a biostatistician at the University of Washington, spent the day testifying in Atlantic City in the personal injury trial of Frederick "Mike" Humeston, an Idaho postal worker who suffered a heart attack while taking Vioxx in 2001. Kronmal, who has done consulting work for pharmaceutical companies but signed on as a $500-an-hour expert for Humeston, said Merck should have moved swiftly to protect clinical trial subjects once the risk was identified by one of the company's statisticians in an April 2001 memo.
"To me, that was scientific misconduct," he said. "The trial should have been stopped."
http://www.nj.com/business/ledger/index.ssf?/base/business-0/11274540734710.xml&coll=1
No comments:
Post a Comment